MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation
- PMID: 11685209
- DOI: 10.1038/ng762
MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation
Erratum in
- Nat Genet 2002 Jan;30(1):123
Abstract
The gene MID1, the mutation of which causes X-linked Opitz G/BBB syndrome (OS, MIM 300000), encodes a microtubule-associated protein (MAP). We show that mutation of MID1 leads to a marked accumulation of the catalytic subunit of protein phosphatase 2A (PP2Ac), a central cellular regulator. PP2Ac accumulation is caused by an impairment of a newly identified E3 ubiquitin ligase activity of the MID1 protein that normally targets PP2Ac for degradation through binding to its alpha4 regulatory subunit in an embryonic fibroblast line derived from a fetus with OS. Elevated PP2Ac causes hypophosphorylation of MAPs, a pathological mechanism that is consistent with the OS phenotype.
Similar articles
-
MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.BMC Cell Biol. 2002;3:1. doi: 10.1186/1471-2121-3-1. Epub 2002 Jan 4. BMC Cell Biol. 2002. PMID: 11806752 Free PMC article.
-
Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6650-5. doi: 10.1073/pnas.111154698. Epub 2001 May 22. Proc Natl Acad Sci U S A. 2001. PMID: 11371618 Free PMC article.
-
Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.BMC Cell Biol. 2004 Feb 29;5:9. doi: 10.1186/1471-2121-5-9. BMC Cell Biol. 2004. PMID: 15070402 Free PMC article.
-
The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.Bioessays. 2003 Apr;25(4):356-66. doi: 10.1002/bies.10256. Bioessays. 2003. PMID: 12655643 Review.
-
The MID1 protein is a central player during development and in disease.Front Biosci (Landmark Ed). 2016 Jan 1;21(3):664-82. doi: 10.2741/4413. Front Biosci (Landmark Ed). 2016. PMID: 26709798 Review.
Cited by
-
The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.J Biol Chem. 2013 Jul 19;288(29):21341-21350. doi: 10.1074/jbc.M113.481093. Epub 2013 Jun 5. J Biol Chem. 2013. PMID: 23740247 Free PMC article.
-
De-repression of myelin-regulating gene expression after status epilepticus in mice lacking the C/EBP homologous protein CHOP.Int J Physiol Pathophysiol Pharmacol. 2014 Dec 15;6(4):185-98. eCollection 2014. Int J Physiol Pathophysiol Pharmacol. 2014. PMID: 25755840 Free PMC article.
-
Alpha4 is an essential regulator of PP2A phosphatase activity.Mol Cell. 2009 Oct 9;36(1):51-60. doi: 10.1016/j.molcel.2009.09.025. Mol Cell. 2009. PMID: 19818709 Free PMC article.
-
Naja atra Cardiotoxin 3 Elicits Autophagy and Apoptosis in U937 Human Leukemia Cells through the Ca2+/PP2A/AMPK Axis.Toxins (Basel). 2019 Sep 12;11(9):527. doi: 10.3390/toxins11090527. Toxins (Basel). 2019. PMID: 31547294 Free PMC article.
-
Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome.Mol Syndromol. 2017 Dec;9(1):45-51. doi: 10.1159/000479177. Epub 2017 Aug 29. Mol Syndromol. 2017. PMID: 29456483 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases